The Endocrine Society has noted that the rodent C-cell tumor findings, while appropriately triggering regulatory caution, have not translated into demonstrated human risk across the now extensive clinical trial and post-marketing experience with GLP-1 receptor agonists as a class
Refrigerated grade tamper-evident caps export-only multi-vial presentation
Effectiveness: Comparable to injections
Research has found that not only does stopping treatment typically result in weight regain, but it can also worsen cardiometabolic risk factors like obesity, high blood pressure , high cholesterol, and insulin resistance
Sermorelin (GHRH 129 NH) is a synthetic 29-amino acid analogue representing the biologically active N-terminal fragment of endogenous growth hormone-releasing hormone (GHRH 144)
You can book a consultation to get a personalised protocol and pricing